Stockreport

Aytu BioScience's (AYTU) CEO Josh Disbrow on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha]

Aytu BioPharma, Inc.  (AYTU) 
NASDAQ:AMEX Investor Relations: aytubio.com/investors/stock-information
PDF Aytu BioScience, Inc. (NASDAQ: AYTU Company Participants Josh Disbrow – Chairman and Chief Executive Officer Dave Green – Chief Financial Officer Conference Call Partici [Read more]